David Shaw’s Disc Medicine IRON Stock Holding History
Bought
Maintained
Sold
Other funds holding IRON
David Shaw's IRON Position: Q3 2026 in Review
David Shaw increased its Disc Medicine (IRON) stake by 606% in Q3 2026, buying an estimated $2.76M and bringing the position to 42,549 shares worth $2.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2957.
David Shaw first reported a position in IRON in Q4 2021 and has held it in 5 quarters since. The position peaked at $10.9M in Q1 2025. 236 funds tracked by Wall St. Rank hold IRON as of Q3 2026.
- David Shaw held 42,549 shares of Disc Medicine worth $2.79M as of Q3 2026.
- David Shaw bought 36,522 Disc Medicine shares in Q3 2026, an estimated $2.76M.
- Disc Medicine made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #2957 holding.
- David Shaw first reported a position in Disc Medicine in Q4 2021 and has held it in 5 quarters since.
- David Shaw's Disc Medicine position peaked at $10.9M in Q1 2025.
- 236 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.